BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Syngene International Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
539268
ISIN Demat
INE398R01022
Book Value (Rs)
104.1404189
NSE Symbol
SYNGENE
Divident Yield %
1.85
Market Cap
(Rs In Cr.)
27,101
P/E (TTM)
56.96
EPS (TTM)
11.82
Face Value
(Rs)
10
Back
Syngene International consolidated net profit rises 5.54% in the March 2024 quarter
25-Apr-24   Hrs IST

Net profit of Syngene International rose 5.54% to Rs 188.60 crore in the quarter ended March 2024 as against Rs 178.70 crore during the previous quarter ended March 2023. Sales declined 7.79% to Rs 916.90 crore in the quarter ended March 2024 as against Rs 994.40 crore during the previous quarter ended March 2023.

For the full year,net profit rose 9.82% to Rs 510.00 crore in the year ended March 2024 as against Rs 464.40 crore during the previous year ended March 2023. Sales rose 9.26% to Rs 3488.60 crore in the year ended March 2024 as against Rs 3192.90 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales916.90994.40 -8 3488.603192.90 9
OPM %34.5631.59 -29.0829.26 -
PBDT320.10326.50 -2 1057.80960.10 10
PBT209.00230.90 -9 631.90593.60 6
NP188.60178.70 6 510.00464.40 10

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)